Human Recombinant HSP90-alpha Protein

$175.00$430.00

The Human Recombinant HSP90-alpha Protein is intended for research use only and not intended for use in diagnostic procedures.

SKU: SPR-101 Categories: ,

Human Recombinant HSP90-alpha Protein

The Human Recombinant HSP90-alpha Protein is For Research Use Only

Specificity: ~90 kDa
Species: Human
Expression System: E. coli
Buffer: 50mM Tris/HCl pH7.5, 5mM Bme, 0.3M NaCl, 10% glycerol
Storage Temperature: -20ºC

Product manufactured in Canada by StressMarq.


Scientific Background

HSP90 is a highly conserved and essential stress protein that is expressed in all eukaryotic cells. From a functional perspective, HSP90 participates in the folding, assembly, maturation, and stabilization of specific proteins as an integral component of a chaperone complex. Despite its label of being a heat-shock protein, HSP90 is one of the most highly expressed proteins in unstressed cells (1–2% of cytosolic protein). It carries out a number of housekeeping functions – including controlling the activity, turnover, and trafficking of a variety of proteins. Most of the HSP90-regulated proteins that have been discovered to date are involved in cell signaling. The number of proteins now know to interact with HSP90 is about 100. Target proteins include the kinases v-Src, Wee1, and c-Raf, transcriptional regulators such as p53 and steroid receptors, and the polymerases of the hepatitis B virus and telomerase. When bound to ATP, HSP90 interacts with co-chaperones Cdc37, p23, and an assortment of immunophilin-like proteins, forming a complex that stabilizes and protects target proteins from proteasomal degradation. In most cases, HSP90-interacting proteins have been shown to co-precipitate with HSP90 when carrying out immunoadsorption studies, and to exist in cytosolic heterocomplexes with it. In a number of cases, variations in HSP90 expression or HSP90 mutation has been shown to degrade signaling function via the protein or to impair a specific function of the protein (such as steroid binding, kinase activity) in vivo. Ansamycin antibiotics, such as geldanamycin and radicicol, inhibit HSP90 function.


Related Products

Active Human Recombinant Tau (K18), P301L mutant Protein Monomer
Active Human Recombinant Tau441 (2N4R) mutant Protein Monomer
Active Human Recombinant A53T Mutant SNCA Protein Preformed Fibrils (Type 1)

Documents


Product Citations